Johns Hopkins Alumnus Nate Hughes, MPP
8th Orphan Drugs & Rare Diseases 2018 Americas Congress – East Coast Boston MA, USA.
The growth of the global orphan drugs market is increasing at a very rapid pace due to the growing rare diseases so global collaboration is likely to fuel growth.
In the photo are executives from Schonermark, Kielhorn, and Collegen from Hannover, Germany, including its President & CEO, Matthias P. Schonermark (Right). Nate Hughes (Center) Schonermark, Kielhorn, and Collegen (Executive on left).